U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri’s PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation Syndrome

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://pluri-biotech.com/wp-content/uploads/2023/07/1689056470_PLUR_NIAID_ARS_PR_FINAL-2.pdf
Research Institution
Pluri Inc.
Short Title
U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri’s PLX-R18
Content Coordinator
Claudia Wair